Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Roche plans to launch Phase 3 studies of its leading obesity candidate ...

Roth believes that potential upside from clinical data expected later this year, combined with above-consensus expectations for its lead drug, could boost Insmed . The investment firm initiated the ...

When Emma* decided to try for a baby, she began to come off some of the medicines she relied on to manage her Ehlers-Danlos syndrome. The complex condition affecting connective tissues has left the 35 ...

SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca (AZN.L), opens new tab has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial ...

Eli Lilly and Company announced in December that its next-generation weight loss drug retatrutide helped patients shed more pounds than any other similar weight-loss drug during a late-stage trial.

The FDA has released new draft guidance outlining the use of Bayesian methodologies in clinical trials for drugs and biologics. The guidance is intended to help sponsors apply modern statistical ...

LEXINGTON, Ky. (WKYT) - Lawyers representing Brian Epperson are asking a judge to delay his federal trial, which is scheduled to start early next month. Epperson was indicted for distributing meth, ...

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

Add Yahoo as a preferred source to see more of our stories on Google. Georgia says her health is 99% better since taking part in the drug trial [Family photo] An teenage dancer who feared her dream of ...

An teenage dancer who feared her dream of a career on the stage was over when she was diagnosed with bowel disease said participating in a clinical trial has drastically improved her health. Georgia ...

SAGINAW, MI — With a prison term hanging over his head, a Saginaw man did not show up for sentencing after pleading guilty to eight gun and drug crimes. Two years on, he’s back in jail and charged ...

Alumis (ALMS) shares climbed nearly 150% on Tuesday after the autoimmune disease drug developer said its lead candidate, envudeucitinib, reached the main goals in two Phase 3 trials for a skin ...